# OnCo record nct00268463 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00268463/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00268463", "NCT00268463" ;
  schema:name "Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer"@en ;
  schema:description "A phase 3 trial of Capecitabine, Floxuridine and Oxaliplatin in Colorectal cancer and Metastatic cancer, run by NSABP Foundation Inc, recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct00268463/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00268463> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/floxuridine/>, <https://onco.cc/drugs/oxaliplatin/> .